Boston Scientific Corp. (NYSE: BSX), a leading global medical device manufacturer, is facing an unusual period of stagnation. Known for delivering consistent performance over the years, the company’s stock has treaded water for the last six months. But with the…
Our main focus
- Politics
- Business
- Economy
- Finance
- Investment
know us
- About
- Contact
- Donation
- Advertise
- Help
The NewYorkBudgets is an independently operated digital news outlet focused on business, finance, and wealth rejuvenation. This platform is currently run as a sole proprietorship and is not yet registered as a formal company. All content is authored and published by independent journalists, with a commitment to honest reporting and reader-first journalism. Revenue may be generated through advertising and reader-supported contributions. A formal business registration will follow as the platform grows.
© 1998-2025 The NewYorkBudgets
Politics
Business
- Economy
- Economic Policy
- Finance
- Investment
- Tech & AI
- Energy
- Tariffs
- Media
- Airlines
- Cars & EVs
- Consumer
- Food & Beverage
- Bankruptcy
Investment
- Finance
- Market
- Wall Street
- Private Equity
- Venture Capital
- Central Banking
- Markets Data
- Cryptocurrency
- Dow Jones Industrial Average
- S&P 500
- Nasdaq Composite
- NYSE Composite
- Russell 2000 Index
Others
- Newsletters
- Podcastes
- Books Review
- Movies Review
- Games Review
- Calculators
- Widgets
- Games
- Videos
- Tools
- Shop
The NewYorkBudgets is an independently operated digital news outlet focused on business, finance, and wealth rejuvenation. This platform is currently run as a sole proprietorship and is not yet registered as a formal company. All content is authored and published by independent journalists, with a commitment to honest reporting and reader-first journalism. Revenue may be generated through advertising and reader-supported contributions. A formal business registration will follow as the platform grows.
© 1998-2025 The NewYorkBudgets